UFPT vs VRTX · P/E 26, rev $148.9M vs P/E 30, rev $3.33B
UFP Technologies Inc (UFPT) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
UFP Technologies Inc (UFPT) is a medical devices company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported UFPT revenue for 2025-12-31 was $148.9M. Net income was $17.6M. Revenue was down 1.5% from 2025-06-30 to 2025-12-31. UFPT currently screens at market cap $1.76B and trailing P/E 26.0.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
UFPT currently screens at market cap $1.76B and trailing P/E 26.0. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the UFPT and VRTX stock pages for the full models.
Not investment advice.